For the 13th year in a row, Global Competition Review (GCR) has named Bates White to its “Economics 23” list (formerly “Economics 21”). Inclusion on the list indicates that a firm is among the world’s leading antitrust economics consultancies and has advised clients on some of the most complicated competition matters in the world.
In focusing on both consulting and litigation competition work Bates White did in 2021, which included 59 mergers, GCR profiles Cory Capps’ work in the Jefferson Health–Einstein Healthcare Network merger that the Federal Trade Commission (FTC) attempted to block. Dr. Capps testified at the preliminary injunction hearing, and the FTC ultimately dropped its challenge. GCR also describes the firm’s support for the FTC on several matters, including its successful challenges to the joint venture between Peabody Energy Corporation and Arch Resources and Heidelberg Cement’s proposed acquisition of Keystone Cement Company. On the litigation side, GCR highlighted the firm’s work on behalf of defendants in In re Packaged Seafood Antitrust Litigation and on behalf of plaintiffs in both In re Rail Freight Fuel Surcharge Antitrust Litigation and the LIBOR-Based Financial Instruments Antitrust Litigation.
The “Economics 23” ranking is based on measures including the number of dedicated antitrust economists in the firm, work over the past year, and the number of nominations to Who’s Who Legal: Competition. In 2021, 9 Bates White competition economists were named to that list: B. Douglas Bernheim, Cory Capps, Eric Emch, Joseph Farrell, Nicholas Hill, Robert Marshall, Leslie Marx, George Rozanski, and Michael Whinston. Drs. Bernheim, Capps, Emch, Farrell, Hill, Rozanski, and Whinston were also recognized as WWL Thought Leaders in Competition.
GCR states that Bates White is “trusted by top law firms, companies, and government agencies alike.” The firm’s 2022 Economics 23 profile is available here.
GCR’s 2022 overview is available here.
